COVID-19 vaccine tracker and landscape
These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020 global of the novel coronavirus.www.who.int
Oxford plans to run phase 3 (AstraZenaca) to July 2021,
Moderna has their study completing in October 2022.
Keep in mind that study completion dates can be very misleading. A typical Phase 3 vaccine study will takes years. But then again, a typical Phase 1 study also takes a year or two, and we are seeing multiple companies skipping straight from Phase 1 to Phase 3 within months now.
All the Phase 1 studies technically have "completion" dates in 2021 as well, and all the advancements to Phase 3 are based on preliminary readouts. Since safety and efficacy are going to be continuously monitored during Phase 3, these companies are all writing in a year or two of observation, while simultaneously hoping to detect an efficacy signal well before then. It seems inevitable that emergency use authorization, and possibly even full approvals, will also be based on preliminary readouts, this time for both safety and efficacy.
I'm still putting my money on at least 1 EUA occurring before the election. It's become too much of a political issue to assume that science alone will guide this decision.
